Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.
Patent CN106187657A reveals stable PdMgAl-LDH catalyst for Suzuki reactions. Reduces palladium pollution and enables scalable pharmaceutical intermediates manufacturing with cost efficiency.
Patent CN107686457B reveals a ferrous salt-catalyzed synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN115353497A reveals a metal-free photocatalytic route for beta-C benzothiazole ethers, offering cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN112159380B discloses a safe, low-temperature route for Barosavir intermediates, eliminating toxic reagents and enabling cost reduction in API manufacturing.
Patent CN107827764A reveals ionic liquid catalysis for bis-beta-amino ketones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable routes.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
New patent CN116715573B reveals high-yield synthesis route for 2 2-dimethylbutyryl chloride offering significant purity improvements and supply chain stability for pharmaceutical manufacturers.
Novel iron-catalyzed method for stereoselective synthesis of heterocyclic intermediates. Reduces heavy metal reliance and enables efficient deuterium labeling for drug development.
Novel copper catalyzed route offers high yield quinoline amides. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel air-stable palladium carbene synthesis offers improved stability and simplified purification for catalytic applications and reliable supply chain solutions.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102850379B details high-yield 7-MAC synthesis. Offers supply chain reliability and cost reduction for cephalosporin intermediate manufacturing.
Discover a novel metal-free amidation method via patent CN111039813B. Achieve cost reduction in pharmaceutical manufacturing with mild conditions and high yields.
Novel supramolecular method achieves >99.9% purity resveratrol by removing 3,4'-dihydroxystilbene. Green, scalable process for pharmaceutical intermediates.
Patent CN114349687B reveals metal-free asymmetric hydrogenation. Enhances safety and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.
Patent CN113105329B details a palladium-free synthesis route for estrogen antagonist intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN105820166A enables green photocatalytic synthesis of dihydrocarboline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.